Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Europe: 4 Urban communities for a Paramount Social Experience - 2Nature's Best: A Manual for Beautiful Train Rides
- 3Which One Energizes You the Most These Tech Developments
- 4'Supergirl' drops 1st teaser trailer: Watch Milly Alcock as Kara Zor-El and the return of Krypto the Superdog
- 5Figure out How to Streamline Eco-friendliness in Your Volvo XC40
- New studies of old dogs help scientists understand where they came from
- Luigi Mangione‘s lawyers say Bondi’s death penalty decision was tainted by conflict of interest
- UK to hold fresh pork, other affected Spanish products at border amid African swine fever outbreak
- Artemis II crew take new photo of far side of the moon
- Consume Fat Quick: 10 Demonstrated Activities for Ideal Outcomes
- Phenomenal Web-based MBA Stages for Proficient Headway
- 'Stranger Things' Season 5: What's going on with Will Byers? That shocking Volume 1 plot twist, explained.
- Finding the Universe of Workmanship: Individual Encounters in Imagination
- New science points to 4 distinct types of autism
